Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?

Sara-Anna Davies Daunas, Xavier Flor-Escriche, Sílvia Álvarez-Álvarez, Maria-Victòria Feijóo-Rodríguez, Laia Lamarca-Fornell
European Respiratory Journal 2016 48: PA3947; DOI: 10.1183/13993003.congress-2016.PA3947
Sara-Anna Davies Daunas
1Family Medicine, CAP Chafarinas. Barcelona ICS, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Flor-Escriche
1Family Medicine, CAP Chafarinas. Barcelona ICS, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sílvia Álvarez-Álvarez
1Family Medicine, CAP Chafarinas. Barcelona ICS, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria-Victòria Feijóo-Rodríguez
2Health Department, Barcelona ICS, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laia Lamarca-Fornell
3Family Medicine, CAP Bigues i Riells. ABS Vall de Tenes, Bigues i Riells, BarcelonaSpain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: COPD guidelines GOLD 2011 and GesEPOC 2012 emerged almost simultaneously, recommending a new approach on COPD, causing some confusion amongst health professionals.

Aims and objectives:

1. To determinate the number of patients that are being correctly treated with inhaled corticosteroids (ICS) according to the disease's stage and the different guides.

2. To determinate the percentage of patients treated correctly according to the stage, severity and guide used (GOLD or GesEPOC).

Methodology: Multicentre transversal study in Barcelona city. A total of 401 patients diagnosed of COPD (FEV1/FVC after bronchodilatiation < 0,70 in spirometry testing), from 6 Primary Attention centres, were included. The treatment prescribed to the patients was analyzed and compared to the recommendations given in both guides. Statistical bivariate analysis was followed.

Results: If we analyse the ICS treatment according to GOLD's classification, the highest percentage of prescribed ICS is in stage B (81,5%). Although according to GesEPOC's, we find it in phenotype D (80%). The adequacy of prescribed treatment according to GOLD's guide is correct in 89,5% of the patients in stage B. On the other hand, according to GesEPOC's guide, 70,6% of phenotype C patients have ICS adequately prescribed.

Conclusions: There is a high percentage of patients in mild and moderate stages who should not have ICS prescribed conceding with GOLD's guide. Conversely, the same happens with phenotype A patients regarding GesEPOC's guide. ICS prescription is accurate in the other stages and phenotypes. Globally, we can observe a better treatment adequacy in mild and very severe stages (GOLD), and in phenotypes A and C (GesEPOC).

  • COPD - management
  • Primary care
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?
Sara-Anna Davies Daunas, Xavier Flor-Escriche, Sílvia Álvarez-Álvarez, Maria-Victòria Feijóo-Rodríguez, Laia Lamarca-Fornell
European Respiratory Journal Sep 2016, 48 (suppl 60) PA3947; DOI: 10.1183/13993003.congress-2016.PA3947

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?
Sara-Anna Davies Daunas, Xavier Flor-Escriche, Sílvia Álvarez-Álvarez, Maria-Victòria Feijóo-Rodríguez, Laia Lamarca-Fornell
European Respiratory Journal Sep 2016, 48 (suppl 60) PA3947; DOI: 10.1183/13993003.congress-2016.PA3947
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Clinical and economic factors associated with spirometry-diagnosed COPD in the Swedish ARCTIC study
  • Using a mobile app to motivate exercise in persons with COPD: A mixed method study
  • ICS and risk of pneumonia in Swedish COPD patients: The ARCTIC study
Show more 1.6 General Practice and Primary Care

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society